Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 | Zendy

Matthew G. Johnson | Zendy; Amy Puenpatom | Zendy; Pablo Andrés Moncada | Zendy; Lesley Burgess | Zendy; Elizabeth R. Duke | Zendy; Norio Ohmagari | Zendy; Timo Wolf | Zendy; Matteo Bassetti | Zendy; Sanjay Bhagani | Zendy; Jade Ghosn | Zendy; Ying Zhang | Zendy; Hong Wan | Zendy; Angela WilliamsDiaz | Zendy; Michelle Brown | Zendy; Amanda Paschke | Zendy; Carisa De Anda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

Author(s) -

Matthew G. Johnson,

Amy Puenpatom,

Pablo Andrés Moncada,

Lesley Burgess,

Elizabeth R. Duke,

Norio Ohmagari,

Timo Wolf,

Matteo Bassetti,

Sanjay Bhagani,

Jade Ghosn,

Ying Zhang,

Hong Wan,

Angela WilliamsDiaz,

Michelle Brown,

Amanda Paschke,

Carisa De Anda

Publication year - 2022

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m22-0729

Subject(s) - medicine , covid-19 , psychological intervention , respiratory system , intensive care medicine , betacoronavirus , virology , disease , infectious disease (medical specialty) , outbreak , nursing

In the MOVe-OUT trial, molnupiravir showed a clinically meaningful reduction in the risk for hospitalization or death in adults with mild to moderate COVID-19 and risk factors for progression to severe disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research